NanoEcho AB (publ) (STO:NANECH)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0433
-0.0016 (-3.56%)
At close: Mar 4, 2026
Market Cap13.15M -43.2%
Revenue (ttm)487.00K -93.3%
Net Income-15.65M
EPS-0.06
Shares Out292.94M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,992,049
Average Volume2,136,024
Open0.0435
Previous Close0.0449
Day's Range0.0390 - 0.0455
52-Week Range0.0403 - 0.2085
Betan/a
RSI39.30
Earnings DateFeb 12, 2026

About NanoEcho AB

NanoEcho AB (publ) engages in developing diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol NANECH
Full Company Profile

Financial Performance

In 2025, NanoEcho AB's revenue was 487,000, a decrease of -93.30% compared to the previous year's 7.27 million. Losses were -15.65 million, 3.35% more than in 2024.

Financial Statements